SOPHiA GENETICS (SOPH) Net Equity Issued and Repurchased (2020)

SOPHiA GENETICS (SOPH) reported Net Equity Issued and Repurchased of $43.0 million for Q3 2020.

SOPHiA GENETICS (SOPH) Net Equity Issued and Repurchased (2020) Analysis & Trends

SOPHiA GENETICS (SOPH) has 1 years of Net Equity Issued and Repurchased data on file, last reported at $43.0 million in Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Veeva Systems 31.81 Bn 24.49 Bn 662.02 Mn -
2 BrightSpring Health Services 14.76 Bn 13.86 Bn 482.22 Mn -
3 Healthequity 8.36 Bn 8.10 Bn 256.31 Mn -
4 Hinge Health 5.91 Bn 5.60 Bn 154.23 Mn -
5 10x Genomics 5.89 Bn 5.35 Bn 106.18 Mn -
6 MiniMed 4.45 Bn 4.16 Bn 480.00 Mn -
7 Waystar Holding 4.41 Bn 4.35 Bn 216.84 Mn -
8 Doximity 3.93 Bn 3.18 Bn 125.97 Mn -
9 Privia Health 3.10 Bn 2.68 Bn - -
10 SOPHiA GENETICS 381.60 Mn 311.31 Mn 14.69 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2020 42.98 Mn
Sep 30, 2020 42.98 Mn